Mepolizumab-associated acute pancreatitis: a case report
Authors: Fiore Casale, Irum Jan
Background: Drug hypersensitivity reactions commonly generate systemic syndromes but can also affect specific organs. Mepolizumab, a monoclonal antibody targeting interleukin-5, is a safe and effective Food and Drug Administration-approved biologic therapy for severe eosinophilic asthma. Case Presentation: A 49-year-old female developed acute pancreatitis complicated by acute hypoxic respiratory failure secondary to fluid overload. Following 72 hours of intravenous fluids and analgesic administration, an urticarial rash developed on the patient’s trunk, raising concern for a drug-related exanthem. After medication reconciliation, it was deemed that she had a hypersensitivity reaction to mepolizumab. Conclusion: In several clinical trials, mepolizumab demonstrated few hypersensitivity reactions. This patient presentation highlights the importance of strong clinical suspicion for drug hypersensitivities, especially in patients failing to respond to the standard of care for common medical conditions.
Keywords: allergy, hypersensitivity, mepolizumab, pancreatitis, DRESS
Authors
Correspondence to:
Irum Jan, University of New Mexico Albuquerque, New Mexico, 87131, USA irum.jan@va.gov
Publication history:
Received 11 Oct 2021
Revised 30 Nov 2021
Accepted 18 Dec 2021
Published online 28 Feb 2022
Published in print 08 Mar 2022
Casale F, Jan I. Mepolizumab-associated acute pancreatitis: a case report. https://www.ejmcr.com/?mno=130762 [Access: May 10, 2024]. doi:
10.24911/ejmcr/173-1633552787
Casale F, Jan I. Mepolizumab-associated acute pancreatitis: a case report. EJMCR. (2022), [cited May 10, 2024]; 6(2): 39-42. doi:
10.24911/ejmcr/173-1633552787
Casale, Fiore, and Irum Jan. 2022. Mepolizumab-associated acute pancreatitis: a case report. European Journal of Medical Case Reports, 6 (2), 39-42. doi:
10.24911/ejmcr/173-1633552787
Casale, Fiore, and Irum Jan. "Mepolizumab-associated acute pancreatitis: a case report." European Journal of Medical Case Reports 6 (2022), 39-42. doi:
10.24911/ejmcr/173-1633552787
Casale, Fiore, and Irum Jan. "Mepolizumab-associated acute pancreatitis: a case report." European Journal of Medical Case Reports 6.2 (2022), 39-42. Print. doi:
10.24911/ejmcr/173-1633552787
Casale, F. & Jan, . I. (2022) Mepolizumab-associated acute pancreatitis: a case report. European Journal of Medical Case Reports, 6 (2), 39-42. doi:
10.24911/ejmcr/173-1633552787